Company page

Vistagen Therapeutics, Inc.

Vistagen Therapeutics, Inc. is a public company traded under the ticker VTGN in the American market. The company has a market capitalization of approximately $25.6 million. Vistagen is focused on developing treatments for central nervous system disorders.

profileVTGNAI content: aiUpdated May 25, 2026/company/vistagen-therapeutics-inc
Vistagen Therapeutics, Inc. logo
Ticker
VTGN
Market cap
$25.6M
Sector
Health Technology
Industry
Biotechnology